Study record · Epitalon
Epitalon in retinitis pigmentosa
The publication reported a positive clinical effect in approximately 90% of treated cases.
Key result
The publication reported a positive clinical effect in approximately 90% of treated cases.
Study details
Study designOlder clinical study
PopulationPatients with retinitis pigmentosa
Sample size162
RouteParabulbar ophthalmic injection
Regimen / exposure5 micrograms per eye daily
Duration10 consecutive days
ComparatorHistorical clinical comparator/context
Primary endpoint / questionVisual/retinal clinical outcomes
Safety resultModern standardized adverse-event reporting was limited.
Key limitationsOlder regional ophthalmic study; route and indication are highly specific and cannot support systemic longevity claims.
Registry / identifierPMID 12195242